Birth defects are the number one cause of the most important threat to child survival and quality of life. At present, China has 1.2 million new birth defects each year, and the national birth defect monitoring data shows that precocious heart disease has become the first birth defect disease in China for ten consecutive years, with a four-fold increase in ten years. If the proportion of congenital heart disease in all birth defects is calculated according to the incidence of 1 per 1,000 live births, China has 200,000 new cases of congenital heart disease every year, and the annual cost of surgery for congenital heart disease must be 12 billion RMB. Congenital heart disease has a long-term and far-reaching impact on the development of people throughout their lives, affecting not only the growth and development of childhood, but also the quality of survival in adulthood, seriously restricting the sustainable development of China’s population and environmental resources, and affecting the development of our national economy. Precocious heart disease is currently the number one cause of death among children under 5 years of age in China, and is also the leading cause of death among newborns and small infants (less than 3 months old). Infant mortality rate and under-five mortality rate are one of the three major indicators of national health and social progress, which reflect the level and quality of development of a region and also represent the image and status of the region. In recent years, with the development of surgery and related technology for precocious heart disease, the comprehensive treatment effect of neonatal and small infant precocious heart disease mainly by surgical treatment has improved year by year, and the treatment level of precocious heart disease in major hospitals has also made great progress. At present, the success rate of surgery for simple precocious diseases reaches 98%, which is at the international level; all procedures for complex precocious diseases can be performed, and some special types of complex precocious diseases have been innovated, and a series of internationally recognized clinical research results have been achieved. On the other hand, with the gradual improvement of the social security system, the establishment of the Children’s Mutual Fund, the inclusion of children in the scope of medical insurance, and the donation of social charity and welfare institutions, the treatment of children with precocious heart disease has been strongly guaranteed financially. If children with precocious heart disease do not receive early surgical treatment, pneumonia and heart failure will occur repeatedly, and the cost of hospitalization will increase exponentially, which will not only seriously affect the growth and development of the child, but also impose a heavy economic burden on society and the family. In fact, the proportion of children who can receive early treatment is very limited, especially for newborns and small infants, according to statistics, in several large cardiac centers in Beijing, the proportion of newborns and small infants is only 10-15%, and there is still a large gap between the success rate of correction of some complex cardiac malformations and the international first-class centers. The main reasons for this are: First, the diagnosis and treatment system for precocious heart disease is not yet complete. Even in Beijing, many hospitals that deliver newborns do not have the ability to make preliminary diagnosis and treatment of precocious heart disease, and there is no unified standard of screening, diagnosis and treatment between urban and suburban areas, specialized hospitals, obstetric hospitals and primary hospitals, and there is a gap in the level of understanding of precocious heart disease among relevant medical personnel. There is a serious disconnect, and the consultation and transfer channels are not smooth enough, resulting in a considerable number of children with precocious heart disease missing out on surgery. However, they may die due to hypoxic attacks, heart failure or recurrent infections, and the surviving children may also develop various pathological changes secondary to pulmonary hypertension, pulmonary vascular dysplasia, and extensive collateral circulation formation, resulting in their poor quality of life and imposing a heavy burden on society and families; iii. After receiving timely referral, the level of correction and treatment of congenital heart disease, especially complex malformations, in various cardiac centers The clinical management ability of congenital heart disease, especially complex malformations, still varies, which leads to unsatisfactory surgical results of children and affects their recovery or even leads to death. If children with congenital heart disease can be diagnosed and treated early, most of them will not affect their normal development and can grow up healthily. There are even some complex precardiac diseases such as transposition of the great arteries and complete pulmonary vein malformation drainage, etc. If diagnosed and surgically treated in the neonatal period, the results are very good and the growth and development can be equal to that of normal children, but if left undiagnosed and untreated, the vast majority will die in infancy. In foreign countries, half of the children with precocious heart disease can be cured in the neonatal period or undergo palliative surgery due to the excellent consultation and treatment network and transportation mechanism, while less than 10% of the children in China are diagnosed and treated in the neonatal period, so there is a huge gap compared with the advanced treatment centers abroad. The above-mentioned current situation calls for us to integrate the existing medical resources of congenital heart disease, devote ourselves to improve the monitoring network of congenital heart disease as soon as possible, improve the professional network platform for diagnosis and treatment of congenital heart disease, unite maternity hospitals, pediatric hospitals and treatment centers of congenital heart disease at all levels, cooperate, communicate and promote each other, continuously improve the diagnosis and treatment level, focus on the standardized treatment of congenital heart disease, and establish a national level medical center. and establish a national-level pediatric congenital heart disease rescue and treatment express, so that every child with congenital heart disease can have a healthy and bright future.